Irlanda - engleză - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - glucose monohydrate sodium dihydrogen phosphate dihydrate zinc acetate dihydrate soya oil medium chain triglycerides isoleucine leucine lysine hydrochloride methionine phenylalanine threonine tryptophan, l- valine arginine histidine hyprochloride monohydrate alanine aspartic acid glutamic acid glycine proline serine calcium chloride dihydrate magnesium acetate tetrahydrate sodium acetate sodium chloride potassium acetate sodium hydroxide - emulsion for infusion

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

mercury pharma group ltd - diclofenac sodium - cutaneous spray solution - 40mg/1gram

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

glenwood gmbh - diclofenac sodium - cutaneous spray, solution - 4 percent weight/weight - antiinflammatory preparations, non-steroids for topical use; diclofenac

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - prednisolone sodium phosphate - eye drops solution - 0.5 %w/v - prednisolone

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - glycine; l-proline; l-serine; sodium hydroxide; sodium chloride; sodium acetate trihydrate; potassium acetate; magnesium acetate tetrahydrate; calcium chloride dihydrate; l-alanine; l-histidine hydrochloride monohydrate; sodium dihydrogen phosphate dihydrate; zinc acetate dihydrate; soya oil; medium-chain triglycerides; l-isoleucine; l-leucine; l-phenylalanine; l-threonine; l-valine; l-arginine; l-aspartic acid; l-glutamic acid; l-lysine monohydrochloride; glucose anhydrous; l-tryptophan; l-methionine - infusion - 1.32gram/1litre ; 2.72gram/1litre ; 2.4gram/1litre ; 640mg/1litre ; 865mg/1litre ; 435mg/1litre ; 2.354gram/1litre ; 515mg/1litre ; 353mg/1litre ; 3.88gram/1litre ; 1.352gram/1litre ; 936mg/1litre ; 5.28mg/1litre ; 20gram/1litre ; 20gram/1litre ; 1.872gram/1litre ; 2.504gram/1litre ; 2.808gram/1litre ; 1.456gram/1litre ; 2.08gram/1litre ; 2.16gram/1litre ; 1.2gram/1litre ; 2.8gram/1litre ; 2.72gram/1litre ; 64gram/1litre ; 456mg/1litre ; 1.568gram/1litre

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - l-methionine; l-glutamic acid; glycine; l-proline; l-serine; sodium hydroxide; sodium chloride; sodium acetate trihydrate; potassium acetate; magnesium acetate tetrahydrate; calcium chloride dihydrate; sodium dihydrogen phosphate dihydrate; glucose monohydrate; zinc acetate dihydrate; medium-chain triglycerides; soya oil; omega-3-acid triglycerides; l-isoleucine; l-leucine; l-phenylalanine; l-threonine; l-valine; l-arginine; l-histidine hydrochloride monohydrate; l-alanine; l-aspartic acid; l-lysine monohydrochloride; l-tryptophan - infusion - 1.88gram/1litre ; 3.368gram/1litre ; 1.584gram/1litre ; 3.264gram/1litre ; 2.88gram/1litre ; 781mg/1litre ; 402mg/1litre ; 222mg/1litre ; 2.747gram/1litre ; 686mg/1litre ; 470mg/1litre ; 1.872gram/1litre ; 132gram/1litre ; 5.264mg/1litre ; 20gram/1litre ; 16gram/1litre ; 4gram/1litre ; 2.256gram/1litre ; 3.008gram/1litre ; 3.368gram/1litre ; 1.744gram/1litre ; 2.496gram/1litre ; 2.592gram/1litre ; 1.624gram/1litre ; 4.656gram/1litre ; 1.44gram/1litre ; 2.728gram/1litre ; 544mg/1litre

Malaezia - engleză - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

b.braun medical industries sdn bhd - alanine; aspartic acid; calcium chloride dihydrate; isoleucine; glutamic acid; arginine; leucine; methionine; phenylalanine; proline; serine; threonine; tryptophan; valine; magnesium acetate tetrahydrate; medium chain triglycerides; sodium hydroxide; soya bean oil; zinc acetate; glycine; potassium acetate; sodium acetate trihydrate; sodium dihydrogen phosphate dihydrate; sodium chloride (salt); l-histidine hydrochloride monohydrate; glucose monohydrate for parenteral use; lysine hydrochloride/monohydrochlor -

Regatul Unit - engleză - VMD (Veterinary Medicines Directorate)

dechra limited - hexamine, sodium dihydrogen phosphate anhydrous -

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

onpharma, inc. - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate inj., 8.4% usp neutralizing additive solution is indicated to hasten onset of analgesia and reduce injection pain, by adjusting commercial preparations of lidocaine w/ epinephrine anesthetic solution to a more physiologic ph. not for use as a systemic alkalizer. barash pg, cullen bf, stoelting rk, clinical anesthesia (4th ed. 2001 lippincott williams and wilken). bhatt h, powell kj, jean da, first aid for the anesthesiology boards, an insider's guide (2011, mcgraw-hill medical). cepeda ms, tzortzopoulou a, thackrey m, hudcova j, arora gandhi p, schumann r., adjusting the ph of lidocaine for reducing pain on injection. cochrane database of systematic reviews 2010, issue 12. art. no.: cd006581. chu lf, clinical anesthesiology board review(2005, mcgraw-hill medical). malamed sf,handbook of local anesthesiology(5th ed. 2004, elsevier mosby). miller rd, miller's anesthesia (6th ed. 2004). stoelting rk, miller rd,basics of anesthesia(5th ed. 2007, churchill livingstone el

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

mylan institutional llc - sodium phenylacetate (unii: 48n6u1781g) (phenylacetic acid - unii:er5i1w795a), sodium benzoate (unii: oj245fe5eu) (benzoic acid - unii:8skn0b0mim) - sodium phenylacetate 100 mg in 1 ml - sodium phenylacetate and sodium benzoate injection is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. during acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [see warnings and precautions (5) ]. none. available data with sodium phenylacetate and sodium benzoate injection use in pregnant women are insufficient to identify a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with sodium phenylacetate and sodium benzoate injection. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. g